ResearcherAriel UniversityNo recent work listed

Gary Gellerman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1336-8707; OpenAlex author ID A5003310357. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

New somatostatin-drug conjugates for effective targeting pancreatic cancer. Last author DOI 10.1016/j.bmc.2018.06.032 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elena Ragozin · 1 shared paper, 2018 · strength 0.07
- Paper New somatostatin-drug conjugates for effective targeting pancreatic cancer. DOI 10.1016/j.bmc.2018.06.032 ↗
Ido Wolf · 1 shared paper, 2018 · strength 0.07
- Paper New somatostatin-drug conjugates for effective targeting pancreatic cancer. DOI 10.1016/j.bmc.2018.06.032 ↗
Tamar Rubinek · 1 shared paper, 2018 · strength 0.07
- Paper New somatostatin-drug conjugates for effective targeting pancreatic cancer. DOI 10.1016/j.bmc.2018.06.032 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.